Cutaneous Leishmaniasis Before and After Renal Transplantation; a Case Report
Authors
Gholamali Ghorbani1,*, Seyed Javad Hosseini2, Vahid Pourfarziani3, Javad Ameli3, Mohammad Hossein Akbari4
1Department of Infectious Disease and Tropical Medicine, Baqyatallah Medical University, IR Iran
2Department of Nephrology, Baqyatallah Medical University, IR Iran
3Department of Neurology, Baqyatallah Medical University, IR Iran
4Department of Pathology, Baqyatallah Medical University, IR Iran
*Corresponding Author: Department of Infectious Disease and Tropical Medicine, Baqyatallah Medical University, IR Iran. Email:, [email protected]. Email: [email protected]
Archives of Clinical Infectious Diseases:Vol. 2, issue 1; 33-6
Published online:Jan 31, 2007
Article type:Case Report
How to Cite:Ghorbani G, Hosseini SJ, Pourfarziani V, Ameli J, Akbari MH. Cutaneous Leishmaniasis Before and After Renal Transplantation; a Case Report. Arch Clin Infect Dis. 2007;2(1):. doi:
Abstract
Background:
Cutaneous leishmaniasis is an endemic infectious disease in Iran caused by flagellated protozoa. The most common cause of cutaneous leishmaniasis is L. major. We report a case of disseminated cutaneous leishmaniasis after renal transplantation.
A 50-year old man received renal transplantation three months ago for diabetes mellitus-associated renal failure. Before renal transplantation, he gave the history of insect bite and a single nodule that was clinically diagnosed as local cutaneous leishmaniasis, however, he had not received therapy. Three months after transplantation while he was on immunosuppressive therapy, he was admitted for disseminated cutaneous nodule. Direct smear and pathology detected lieshman body and amastigote in the lesion compatible with the diagnosis of disseminated cutaneous lishmaniasis. Despite difficult therapeutic approach, he cured after combination therapy with glucontim and amphotricin B for one month.
Conclusion:
In countries like Iran where leishmaniasis is endemic, each nodule or chronic skin lesion should be evaluated for cutaneous leishmaniasis. Transplant clinicians should have a high index of suspicion of leishmania infections as an important cause of post transplant morbidity.
Rahbar M, Beladi Mousavi SS, Mousavi MB. Fluconazole in the Treatment of Cutaneous Leishmaniasis in a Kidney Transplant Patient a Case Report. Shiraz E-Med J. 2012;13(4):. doi:
Hazirehyazdi L, Davudi Kia A, Hamzehnezhad M, Mashaei S. Disseminated Cutaneous Leishmaniasis in a Man With Human Immunodeficiency Virus Infection. Int J Infect. 2015;2(3):e25271. doi: https://doi.org/10.17795/iji25271
Shokouhi S, Moghadammi M, Malekzad F, Malekpour F, Roodgari A, et al. Cutaneous Mucormycosis in a Renal Transplanted Man, Case Report and Review of Literature. Shiraz E-Med J. 2007;8(4):. doi:
Demirci M, Baran N, Uzum A, Calli AO, Gul-Yurtsever S, et al. Cutaneous Alternariasis in a Patient With Renal Transplant. Jundishapur J Microbiol. 2015;8(5):e59862. doi: https://doi.org/10.5812/jjm.8(5)2015.19082